Ligand Pharmaceuticals (LGND) Quick Ratio: History & Chart

Ligand Pharmaceuticals Incorporated(LGND)

Biotechnology · Jupiter, FL

$301.47-5.31 (-1.73%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company’s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.

Jupiter, FL

47 employees

www.ligand.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Todd C. Davis

View full financials

LGND Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

30.96

QUICK RATIO (ACID-TEST) AVG TTM

20.69

QUICK RATIO (ACID-TEST) AVG 3Y

15.41

QUICK RATIO (ACID-TEST) AVG 5Y

11.58

QUICK RATIO (ACID-TEST) AVG 10Y

9.68

QUICK RATIO (ACID-TEST) AVG 15Y

6.57

QUICK RATIO (ACID-TEST) AVG 20Y

5.22

CURRENT VS TTM AVG

+49.64%

CURRENT VS 3Y AVG

+100.91%

CURRENT VS 5Y AVG

+167.28%

CURRENT VS 10Y AVG

+219.67%

CURRENT VS 15Y AVG

+371.20%

CURRENT VS 20Y AVG

+493.10%

SECTOR MEDIAN · HEALTHCARE

2.99

median of 565 covered companies

CURRENT VS SECTOR MEDIAN

+935.38%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Ligand Pharmaceuticals Incorporated (LGND)	$6.04B	30.96	20.69	15.41	11.58
Iovance Biotherapeutics, Inc. (IOVA)vs ›	$5.91B	3.82	3.07	3.52	5.23
CG Oncology Inc. (CGON)vs ›	$5.81B	22.20	29.94	20.76	18.56
Kiniksa Pharmaceuticals International, plc (KNSA)vs ›	$5.73B	3.49	3.21	3.75	4.96
Amneal Pharmaceuticals, Inc. (AMRX)vs ›	$6.49B	1.44	1.17	1.11	1.26
Lantheus Holdings, Inc. (LNTH)vs ›	$6.53B	2.89	3.87	3.94	3.31
Hims & Hers Health, Inc. (HIMS)vs ›	$6.52B	0.87	1.56	2.48	3.39
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.58B	1.36	1.16	1.16	1.16
Chemed Corporation (CHE)vs ›	$6.65B	0.89	1.19	1.21	1.11
GRAIL Inc. (GRAL)vs ›	$6.55B	10.74	11.09	6.26	5.77

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Ligand Pharmaceuticals Incorporated (LGND)

$6.04B

30.96

20.69

15.41

11.58

Iovance Biotherapeutics, Inc. (IOVA)vs ›

$5.91B

3.82

3.07

3.52

5.23

CG Oncology Inc. (CGON)vs ›

$5.81B

22.20

29.94

20.76

18.56

Kiniksa Pharmaceuticals International, plc (KNSA)vs ›

$5.73B

3.49

3.21

3.75

4.96

Amneal Pharmaceuticals, Inc. (AMRX)vs ›

$6.49B

1.44

1.17

1.11

1.26

Lantheus Holdings, Inc. (LNTH)vs ›

$6.53B

2.89

3.87

3.94

3.31

Hims & Hers Health, Inc. (HIMS)vs ›

$6.52B

0.87

1.56

2.48

3.39

MiniMed Group, Inc. Common Stock (MMED)vs ›

$5.58B

1.36

1.16

Chemed Corporation (CHE)vs ›

$6.65B

0.89

1.19

1.21

1.11

GRAIL Inc. (GRAL)vs ›

$6.55B

10.74

11.09

6.26

5.77

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The quick ratio (acid-test) for LGND stock is 30.96.

Is Ligand Pharmaceuticals Incorporated's quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 30.96 is 167% above its 5-year average of 11.58, near the high end of its 5-year range (1.30–30.96).

What is the TTM average quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The TTM average quick ratio (acid-test) for LGND stock is 20.69.

What is the 3Y average quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The 3Y average quick ratio (acid-test) for LGND stock is 15.41.

What is the 5Y average quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The 5Y average quick ratio (acid-test) for LGND stock is 11.58.

What is the 10Y average quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The 10Y average quick ratio (acid-test) for LGND stock is 9.68.

What is the 15Y average quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The 15Y average quick ratio (acid-test) for LGND stock is 6.57.

What is the 20Y average quick ratio (acid-test) for Ligand Pharmaceuticals Incorporated (LGND)?

The 20Y average quick ratio (acid-test) for LGND stock is 5.22.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	30.96
2026-03-31	20.95
2025-12-31	21.98
2025-09-30	24.30
2025-06-30	5.25
2025-03-31	5.07
2024-12-31	8.55
2024-09-30	11.95
2024-06-30	16.04
2024-03-31	19.51
2023-12-31	12.72
2023-09-30	14.54
2023-06-30	8.50
2023-03-31	3.18
2022-12-31	2.53
2022-09-30	1.46
2022-06-30	1.30
2022-03-31	5.88
2021-12-31	10.50
2021-09-30	11.00
2021-06-30	7.07
2021-03-31	4.18
2020-12-31	4.74
2020-09-30	19.96
2020-06-30	29.38
2020-03-31	40.29
2019-12-31	65.66
2019-09-30	32.96
2019-06-30	13.15
2019-03-31	8.33
2018-12-31	10.50
2018-09-30	2.19
2018-06-30	2.32
2018-03-31	1.37
2017-12-31	0.97
2017-09-30	0.95
2017-06-30	0.84
2017-03-31	0.74
2016-12-31	0.71
2016-09-30	0.60
2016-06-30	0.56
2016-03-31	10.73
2015-12-31	10.27
2015-09-30	12.87
2015-06-30	10.92
2015-03-31	10.40
2014-12-31	8.12
2014-09-30	10.71
2014-06-30	1.49
2014-03-31	1.50
2013-12-31	0.81
2013-09-30	0.46
2013-06-30	0.38
2013-03-31	0.45
2012-12-31	0.62
2012-09-30	0.50
2012-06-30	0.60
2012-03-31	0.82
2011-12-31	0.71
2011-09-30	0.59
2011-06-30	0.60
2011-03-31	0.61
2010-12-31	1.11
2010-09-30	0.96
2010-06-30	1.00
2010-03-31	1.22
2009-12-31	1.25
2009-09-30	1.96
2009-06-30	2.59
2009-03-31	1.28
2008-12-31	1.31
2008-09-30	1.64
2008-06-30	2.35
2008-03-31	2.27
2007-12-31	2.16
2007-09-30	1.90
2007-06-30	1.92
2007-03-31	1.25
2006-12-31	1.36
2006-09-30	0.26
2006-06-30	0.39
2006-03-31	0.41
2005-12-31	0.53
2005-09-30	0.49
2005-06-30	0.48
2005-03-31	0.58
2004-12-31	0.74
2004-09-30	1.59
2004-06-30	1.74
2004-03-31	2.01
2003-12-31	2.26
2003-09-30	2.16
2003-06-30	1.48
2003-03-31	1.52
2002-12-31	2.58
2002-09-30	1.63

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

30.96

2026-03-31

20.95

2025-12-31

21.98

2025-09-30

24.30

2025-06-30

5.25

2025-03-31

5.07

2024-12-31

8.55

2024-09-30

11.95

2024-06-30

16.04

2024-03-31

19.51

2023-12-31

12.72

2023-09-30

14.54

2023-06-30

8.50

2023-03-31

3.18

2022-12-31

2.53

2022-09-30

1.46

2022-06-30

1.30

2022-03-31

5.88

2021-12-31

10.50

2021-09-30

11.00

2021-06-30

7.07

2021-03-31

4.18

2020-12-31

4.74

2020-09-30

19.96

2020-06-30

29.38

2020-03-31

40.29

2019-12-31

65.66

2019-09-30

32.96

2019-06-30

13.15

2019-03-31

8.33

2018-12-31

10.50

2018-09-30

2.19

2018-06-30

2.32

2018-03-31

1.37

2017-12-31

0.97

2017-09-30

0.95

2017-06-30

0.84

2017-03-31

0.74

2016-12-31

0.71

2016-09-30

0.60

2016-06-30

0.56

2016-03-31

10.73

2015-12-31

10.27

2015-09-30

12.87

2015-06-30

10.92

2015-03-31

10.40

2014-12-31

8.12

2014-09-30

10.71

2014-06-30

1.49

2014-03-31

1.50

2013-12-31

0.81

2013-09-30

0.46

2013-06-30

0.38

2013-03-31

0.45

2012-12-31

0.62

2012-09-30

0.50

2012-06-30

0.60

2012-03-31

0.82

2011-12-31

0.71

2011-09-30

0.59

2011-06-30

0.60

2011-03-31

0.61

2010-12-31

1.11

2010-09-30

0.96

2010-06-30

1.00

2010-03-31

1.22

2009-12-31

1.25

2009-09-30

1.96

2009-06-30

2.59

2009-03-31

1.28

2008-12-31

1.31

2008-09-30

1.64

2008-06-30

2.35

2008-03-31

2.27

2007-12-31

2.16

2007-09-30

1.90

2007-06-30

1.92

2007-03-31

1.25

2006-12-31

1.36

2006-09-30

0.26

2006-06-30

0.39

2006-03-31

0.41

2005-12-31

0.53

2005-09-30

0.49

2005-06-30

0.48

2005-03-31

0.58

2004-12-31

0.74

2004-09-30

1.59

2004-06-30

1.74

2004-03-31

2.01

2003-12-31

2.26

2003-09-30

2.16

2003-06-30

1.48

2003-03-31

1.52

2002-12-31

2.58

2002-09-30

1.63

Quick Ratio (Acid-Test): 30.96

LGND Quick Ratio

LGND Average Quick Ratio (Acid-Test) Chart

LGND Current vs Average Quick Ratio (Acid-Test) Chart

LGND Quick Ratio (Acid-Test) Metrics

LGND Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

LGND Quick Ratio (Acid-Test) History

Related Metrics